_____________________
Presentation
The “Biotherapies – Biotherapies by nucleic acid vectorization” team is developing 3 main lines of research:
* Development of innovative strategies for RNA delivery, small interfering RNAs or mRNAs.
* Pharmacological evaluation of new therapeutic strategies, mainly in the fields of inflammatory diseases, hepatic fibrosis and cancer. fibrosis or cancer.
* Development of tumor-penetrating and tumor-interfering peptides (TP and IP), capable of specifically penetrating tumor cells, without any effect on healthy cells, and blocking the interaction between two proteins deregulated during tumor transformation.
October 2025 – Thesis defense at UTCBS: Mitta PIERRE
On October 1st, 2025, Mitta PIERRE successfully defended her doctoral thesis entitled “Nanoformulations of antioxidant active ingredients for ophthalmic administration in the prevention of age-related macular degeneration (AMD)” supervised by Pr. Christine CHARRUEAU and co-supervised by Dr. Diana LAMAA
September 2025 – [Keynote research] Nathalie Mignet,Head of Laboratory, Nanomedicines and lipid nanoparticles for nucleic acid delivery
[Keynote research] Nathalie Mignet, Nanomedicines and lipid nanoparticles for nucleic acid delivery
July 2025 – Workshop du master erasmus mundus Nanomed
Workshop du master erasmus mundus Nanomed
June 2025 – Université Paris Cité’s Apprentis Chercheurs conference was held last June, with UTCBS taking part.
Université Paris Cité’s Apprentis Chercheurs conference was held last June, with UTCBS taking part.